Streetbeat News

Analyst Ratings

EXAS

Evercore ISI Group has maintained an Outperform rating on Exact Sciences and raised the price target from $72 to $80.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:31 pm

WMT

Deep-pocketed investors are showing a bearish sentiment towards Walmart (NYSE:WMT) in the options market, with 65% of notable options activities being bearish. This unusual activity suggests potential significant price movements. Analysts maintain a generally positive outlook with an average target price of $92.2.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 4:30 pm

EW

Evercore ISI Group has maintained an In-Line rating on Edwards Lifesciences but lowered the price target from $76 to $70.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:30 pm

MARA

MARA Holdings (NASDAQ:MARA) has seen unusual options activity, with a bearish sentiment from big-money investors. The options trades include 9 puts and 21 calls, with a total trade value of over $1.4 million. The stock is currently down 6.72% at $15.13, with a neutral RSI. Analysts have set an average price target of $22.0.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 4:30 pm

NVRO

Citigroup analyst Joanne Wuensch maintains a Neutral rating on Nevro (NYSE:NVRO) and lowers the price target from $6.89 to $6.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:28 pm

ENOV

Evercore ISI Group has maintained an 'Outperform' rating on Enovis (NYSE:ENOV) but has lowered the price target from $62 to $58.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:28 pm

MDT

Citigroup analyst Joanne Wuensch maintains a Neutral rating on Medtronic (NYSE:MDT) but raises the price target from $85 to $92.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:27 pm

NFLX

Netflix is expected to see a boost in its stock valuation due to upcoming content releases, including two NFL games and 'Squid Game' Season 2. Analyst Justin Patterson from KeyBanc Capital Markets has raised the price target for Netflix, citing strong content catalysts in Q4 and potential EPS growth in 2025 and 2026.

Portfolio Pulse from Chris Katje

October 01, 2024 | 4:25 pm

IART

Citigroup analyst Joanne Wuensch maintains a Sell rating on Integra Lifesciences and lowers the price target from $20 to $16.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:25 pm

DHR

Evercore ISI Group has maintained an 'Outperform' rating on Danaher (NYSE:DHR) and raised its price target from $275 to $278.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 4:24 pm